Fludarabine + cyclophosphamide + antithymocyte globulin
Fludarabine + cyclophosphamide + antithymocyte globulin has been studied in 1 paper since 2016: 1 observational study in people. The newest paper, Jun 27, 2016: “Comparable outcomes between younger (⩽40 years) and older (>40 years) adult patients with severe aplastic anemia after HLA-matched sibling stem cell transplantation using fludarabine-based conditioning”.
1 paper studies itUpdated
See all 1 papers on fludarabine + cyclophosphamide + antithymocyte globulin
- Humans1